The NDC code associated with HCPCS code J2787, which represents the Photrexa cross-linking kit, is 25357-025-03.
Understanding J2787 and its Associated NDC
HCPCS Level II code J2787 is designated for "Injection, riboflavin, (photrexa), 1 mg," primarily used in corneal cross-linking procedures. This procedure often involves the Photrexa cross-linking kit, which contains the necessary riboflavin solution. The National Drug Code (NDC) uniquely identifies drug products, providing essential information for billing and inventory management.
Here's a breakdown of the code and its associated NDC:
| Code | Description | Associated NDC |
|---|---|---|
| J2787 | Injection, riboflavin, (photrexa), 1 mg | 25357-025-03 |
Importance of the NDC for Billing
The NDC is crucial for accurate medical billing and ensures proper identification of the specific drug product administered. Many insurance carriers and healthcare payers require the submission of claims with an 11-digit NDC. The NDC 25357-025-03, when formatted to an 11-digit standard, typically appears as 25357-0025-03, where leading zeros are added to the second and third segments to achieve the 5-4-2 format (labeler-product-package code). Understanding the structure and proper formatting of NDCs is vital for healthcare providers to streamline claims processing. For more information on the National Drug Code system, you can refer to the FDA's NDC Directory.
Billing Considerations for J2787
When performing the corneal cross-linking procedure using the Photrexa solution, it's important to understand the typical billing units for J2787. For instance, if the procedure requires the use of 6 mL of solution, it is generally recommended to submit 2 units of J2787. This guidance helps ensure correct reimbursement based on the administered dosage and the product's packaging. Accurate unit reporting directly impacts the claim's validity and the appropriate compensation for the medical service provided.
